ARCHIVES

In Brief: Ross, Harvey To Lead Cancer Center Group; NCI Director In Office By Aug. 1, Varmus Says

This article is from The Cancer Letter archive.

Vol. 21 No. 20 | May 19, 1995

Download PDF Visit The Full Archive

Related Articles

Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment.

July 30, 2004

NCI’s Professional Judgment Budget Outlines Spending of $7.2 Billion

February 13, 2009

Susan Horwitz Succeeds Waun Ki Hong As AACR President

April 12, 2002

US Files Motion To Dismiss Fisher Suit Over Database Flags

November 3, 1995

In Brief: Congressional Action Imminent On Cancer Ac Renewal, Hew Money Bills; Veto Threatened

September 8, 1978

CCOP Success Acknowledged, Recompetition Plans Being Made; Cancer Control May Be Added To RFA

April 11, 1986